Home » Stocks » Cell MedX

Cell MedX Corp (CMXC)

Stock Price: $0.510 USD 0.000 (0.00%)
Updated Aug 5, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 28.52M
Revenue (ttm) 39,480
Net Income (ttm) -1.05M
Shares Out 55.92M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 5, 2020
Last Price $0.510
Previous Close $0.510
Change ($) 0.000
Change (%) 0.00%
Day's Open 0.515
Day's Range 0.490 - 0.515
Day's Volume 21,076
52-Week Range 0.102 - 1.690

More Stats

Market Cap 28.52M
Enterprise Value 28.83M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 55.92M
Float 27.05M
EPS (basic) -0.03
EPS (diluted) -0.02
FCF / Share -0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 1.19
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 722.32
PB Ratio n/a
Revenue 39,480
Operating Income -929,622
Net Income -1.05M
Free Cash Flow -799,892
Net Cash -309,835
Net Cash / Share -0.01
Gross Margin n/a
Operating Margin -2,354.67%
Profit Margin -2,669.70%
FCF Margin -2,026.07%
ROA -260.25%
ROE n/a
ROIC -213.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue--0.010.040.04----
Revenue Growth---82.99%-14.23%-----
Gross Profit---0.010.02----
Operating Income-0.67-1.54-1.22-2.10-0.94-0.02-0.01-0.02-0.01
Net Income-0.91-1.55-1.25-2.14-1.03-0.02-0.01-0.02-0.01
Shares Outstanding44.2842.3136.8631.0031.0031.0031.0030.2730.00
Earnings Per Share-0.02-0.04-0.03-0.07-0.03----
Operating Cash Flow-0.31-0.45-0.75-0.42-0.32-0.01-0.01-0.02-0.02
Capital Expenditures---0.11-0.22-0.03----
Free Cash Flow-0.31-0.45-0.86-0.64-0.34-0.01-0.01-0.02-0.02
Cash & Equivalents0.060.010.070.030.000.000.010.020.00
Total Debt0.510.120.540.950.27----
Net Cash / Debt-0.45-0.11-0.47-0.92-0.270.000.010.020.00
Assets0.190.050.290.270.05-0.010.02-
Liabilities1.961.121.461.680.730.020.010.01-
Book Value-1.77-1.07-1.17-1.41-0.68-0.02-0.01-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Cell MedX Corp
Country United States
CEO Frank E. Mcenulty

Stock Information

Ticker Symbol CMXC
Stock Exchange US OTC
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier OTCMKTS: CMXC

Description

Cell MedX Corp., a development stage company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It also develops and manufactures eBalance technology that is in the research and development stage to manage diabetes mellitus and its complications. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.